BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
IL1A
,
Metabolism of xenobiotics
,
Lung cancer
,
Endothelial cell
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sphingomyelinase
Summary
General Info
Curated Studies
Most Correlated Studies
Human umbilical vein endothelial cells treated with GW4869
NIH3T3 embryonic fibroblasts with c-src[Y527F] mutant
Huh7 cell gene expression in response to HDL from normal and familial hypercholesterolemia patients
Explore Curated Studies Results
Literature
Most Relevant Literature
Acid sphingomyelinase.
Sphingolipid metabolism and neutral sphingomyelinases.
Computational identification and experimental characterization of substrate binding determinants of …
Bacillus cereus sphingomyelinase recognizes ganglioside GM3.
The roles of neutral sphingomyelinases in neurological pathologies.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tolerability and Safety Study of Recombinant Human Acid Sphingomyelinase in Acid Sphingomyelinase De…
Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Aci…
Magnetic Resonance Spectroscopy in Acid Sphingomyelinase Deficiency
Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Ea…
A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ